XML 88 R60.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Shareholders' Deficit (Details)
12 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
$ / shares
Jun. 30, 2024
€ / shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
€ / shares
Jun. 30, 2023
USD ($)
$ / shares
shares
May 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common Stock, Shares, Outstanding         25,080,022   26,344,608  
Share-based compensation expense | $ $ 65,584,000 $ 42,122,000 $ 49,766,000          
Issuance of ordinary shares due to share option exercises, Shares (45,500)              
Share-based Payment Arrangement, Amount Capitalized | $ $ 3,160,000 $ 1,879,000 $ 1,221,000          
Common Stock, Capital Shares Reserved for Future Issuance         1,090,723      
Stock Repurchased During Period, Shares 300,000              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number         338,593   387,447  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares $ 46.20              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ / shares         $ 46.39   $ 46.37  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 7 years 3 months 18 days              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number         148,393      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares         $ 47.17      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 9 years            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $   $ 275,000            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares             $ 124.46  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 70.21              
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number             1,401,744  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (11,011)              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (45,500)              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $ / shares $ 46.20              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares (3,354)              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         1,055,377      
Class of Warrant or Right, Percentage of Securities               3.875%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares         $ 60      
Warrants Not Settleable in Cash, Fair Value Disclosure | $         $ 22,432,000      
Common Stock, Value per Share | € / shares       € 0.01   € 0.01    
Common Stock, Discount on Shares | $         2.14      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $         84,653,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   3.06%            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend   0.00%            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term   4 years 3 days            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate   61.99%            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 22.83            
Shareholders' Equity and Share-based Payments 1,816   41          
Restricted Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 71.42 44.25 $ 80.26          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $     $ 10,123,000   $ 47,661,000   $ 13,544,000  
Restricted share units [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares         $ 62.59   $ 59.27  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 344,268              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 71.42              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (629,381)              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 60.11              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (81,467)              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number         1,103,713   1,470,293  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares $ 59.11              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $         $ 96,696,000      
2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $         $ 13,956,000   $ 5,189,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares         $ 109.48      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 544,120              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 70.21 $ 17.61 $ 110.28          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number         1,934,853      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 76.03              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $     $ 52,875,000   $ 169,512,000   $ 83,376,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $         $ 6,002,000      
Maximum [Member] | 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares Authorized for Grants         5,500,000      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 250.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant         4,356,251      
Minimum [Member] | 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 0.00%